(Q70565913)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8435475%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

title

Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8435475%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

1 reference

F Jänicke

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8435475%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

M Schmitt

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8435475%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

L Pache

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8435475%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

K Ulm

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8435475%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

N Harbeck

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8435475%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

H Höfler

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8435475%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

H Graeff

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8435475%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

publication date

1 January 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8435475%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

12 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8435475%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8435475%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8435475%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

page(s)

195-208

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8435475%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01833260

12 October 2019

exact match

0 references

cites work

Elastase released from human granulocytes stimulated with N-formyl-chemotactic peptide prevents activation of tumor cell prourokinase (pro-uPA)

1 reference

12 December 2020

Prognostic factors for recurrence and survival in human breast cancer

1 reference

12 December 2020

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

12 December 2020

Plasminogen activator content of gynecological tumors and their metastases.

1 reference

12 December 2020

Urokinase plasminogen activator and prognosis in breast cancer

1 reference

12 December 2020

The relevance of plasminogen activators to neoplastic growth. A review of recent literature.

1 reference

12 December 2020

Evaluation of estrogen receptor assays in human breast cancer tissue

1 reference

12 December 2020

Autocrine saturation of pro-urokinase receptors on human A431 cells.

1 reference

12 December 2020

Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA)

1 reference

12 December 2020

Cathepsin D: an independent prognostic factor for metastasis of breast cancer

1 reference

12 December 2020

Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group

1 reference

12 December 2020

Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type 1 inhibitor in breast cancer

1 reference

12 December 2020

Bootstrap investigation of the stability of a Cox regression model

1 reference

12 December 2020

Flow cytometry using paraffin-embedded tissue: five years on.

1 reference

12 December 2020

Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry

1 reference

12 December 2020

Plasminogen activator secretion of human tumors in short-term organ culture, including a comparison of primary and metastatic colon tumors

1 reference

12 December 2020

Urokinase-type plasminogen activator antigen and early relapse in breast cancer

1 reference

12 December 2020

Fibrin-fibronectin compounds in human ovarian tumor ascites and their possible relation to the tumor stroma

1 reference

12 December 2020

Better reception for urokinase

1 reference

12 December 2020

Role of plasmin in the degradation of the stroma-derived fibrin in human ovarian carcinoma

1 reference

12 December 2020

A comparison of estimated proportional hazards models and regression trees.

1 reference

12 December 2020

Cathepsin D and prognosis in breast cancer

1 reference

12 December 2020

Prognostic value of estrogen receptors in primary breast cancer

1 reference

12 December 2020

How to use prognostic factors in axillary node-negative breast cancer patients

1 reference

12 December 2020

Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer

1 reference

12 December 2020

Indicators of prognosis in node-negative breast cancer

1 reference

12 December 2020

Urokinase-plasminogen activator, a new and independent prognostic marker in breast cancer

1 reference

12 December 2020

Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Preliminary report

1 reference

12 December 2020

The plasmin system in human colonic tumors: an immunofluorescence study

1 reference

12 December 2020

A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase

1 reference

12 December 2020

Plasminogen activators, tissue degradation, and cancer

1 reference

12 December 2020

Examination of the role of the urokinase receptor in human colon cancer mediated laminin degradation

1 reference

12 December 2020

Secretion of plasminogen activators by human colorectal and gastric tumor explants

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01833260

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8435475%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

1 reference